Kim Jae J, Lee Jun Haeng, Jung Hwoon-Yong, Lee Gin Hyug, Cho Joo Yong, Ryu Chang Beom, Chun Hoon Jai, Park Jong Jae, Lee Wan Sik, Kim Hyun Soo, Chung Moon Gi, Moon Jeong Seop, Choi Seok Reyol, Song Geun Am, Jeong Hyun Yong, Jee Sam Ryong, Seol Sang Yong, Yoon Yong Bum
Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
Gastrointest Endosc. 2007 Oct;66(4):693-700. doi: 10.1016/j.gie.2007.04.013.
EMR has been accepted as a treatment modality for selected cases of early gastric cancer (EGC) in Japan. However, long-term outcomes after EMR for EGC have not been fully documented.
We reviewed the experiences of EMR for EGC in Korea, with emphasis on the long-term outcome.
Multicenter, retrospective study.
Data were collected retrospectively by use of the on-line database registry system. From January 2000 to December 2002, 514 EGCs in 506 patients were treated by EMR in 13 institutions in Korea. Median age of the patients was 60 years (range 45-83 years). The resection was regarded as incomplete if histopathologic examination revealed a positive resection margin or submucosal invasion or positive lymphovascular invasion or undifferentiated histologic diagnosis.
The most commonly used technique was circumferential precutting followed by snare resection (EMR-P, n = 269, 52.3%). Complete resection and incomplete resection after EMR were confirmed in 399 lesions (77.6%) and 103 lesions (20.0%), respectively. For completely resected mucosal cancers (n = 399), the median duration of follow-up was 23.5 months (range 5-70 months). In this group, local recurrence was detected in 24 cases (6.0%) with a median interval between EMR and recurrence of 17.9 months (range 3.5-51.7 months). There were 3 cases with perforation and 71 cases with bleeding. No deaths were related to recurrence of gastric cancer during the overall median follow-up period of 39 months.
Multicenter retrospective design, no controls.
EMR is an effective therapeutic modality for selected cases of EGC in Korea.
在日本,内镜下黏膜切除术(EMR)已被接受为早期胃癌(EGC)某些病例的一种治疗方式。然而,EGC行EMR后的长期结局尚未得到充分记录。
我们回顾了韩国EGC行EMR的经验,重点关注长期结局。
多中心回顾性研究。
通过在线数据库登记系统进行回顾性数据收集。2000年1月至2002年12月,韩国13家机构对506例患者的514例EGC进行了EMR治疗。患者的中位年龄为60岁(范围45 - 83岁)。如果组织病理学检查显示切缘阳性、黏膜下浸润、淋巴管浸润阳性或组织学诊断为未分化,则切除被视为不完全切除。
最常用的技术是环形预切开后圈套切除(EMR - P,n = 269,52.3%)。EMR后完全切除和不完全切除分别在399个病变(77.6%)和103个病变(20.0%)中得到证实。对于完全切除的黏膜癌(n = 399),中位随访时间为23.5个月(范围5 - 70个月)。在该组中,24例(6.0%)检测到局部复发,EMR与复发之间的中位间隔为17.9个月(范围3.5 - 51.7个月)。有3例穿孔和71例出血。在39个月的总体中位随访期内,没有死亡与胃癌复发相关。
多中心回顾性设计,无对照。
在韩国,EMR是EGC某些病例的一种有效治疗方式。